Menu
Currency
GWAS Study

A Pooled Genome-Wide Association Study of Asperger Syndrome.

Warrier V, Chakrabarti B, Murphy L et al.

26176695 PubMed ID
GWAS Study Type
612 Participants
30 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WV
Warrier V
CB
Chakrabarti B
ML
Murphy L
CA
Chan A
CI
Craig I
MU
Mallya U
LS
Lakatošová S
RK
Rehnstrom K
PL
Peltonen L
WS
Wheelwright S
AC
Allison C
FS
Fisher SE
BS
Baron-Cohen S
Chapter II

Abstract

Summary of the research findings

Asperger Syndrome (AS) is a neurodevelopmental condition characterized by impairments in social interaction and communication, alongside the presence of unusually repetitive, restricted interests and stereotyped behaviour. Individuals with AS have no delay in cognitive and language development. It is a subset of Autism Spectrum Conditions (ASC), which are highly heritable and has a population prevalence of approximately 1%. Few studies have investigated the genetic basis of AS. To address this gap in the literature, we performed a genome-wide pooled DNA association study to identify candidate loci in 612 individuals (294 cases and 318 controls) of Caucasian ancestry, using the Affymetrix GeneChip Human Mapping version 6.0 array. We identified 11 SNPs that had a p-value below 1x10-5. These SNPs were independently genotyped in the same sample. Three of the SNPs (rs1268055, rs7785891 and rs2782448) were nominally significant, though none remained significant after Bonferroni correction. Two of our top three SNPs (rs7785891 and rs2782448) lie in loci previously implicated in ASC. However, investigation of the three SNPs in the ASC genome-wide association dataset from the Psychiatric Genomics Consortium indicated that these three SNPs were not significantly associated with ASC. The effect sizes of the variants were modest, indicating that our study was not sufficiently powered to identify causal variants with precision.

294 European ancestry cases, 318 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

612
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.